Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 18 out of 18Page size: 50
  1. 2021
  2. Published

    Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

    ERIC, the European Research Initiative on CLL, E. T. E. R. I. O. C., 2021, In: Blood. 137, 10, p. 1365-1376 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study

    Andersen, M. A., Rostgaard, K., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: Leukemia. 35, 3, p. 747-751 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study

    Andersen, M. A., Niemann, Carsten, Rostgaard, K., Dalby, T., Sørrig, R., Weinberger, D. M., Hjalgrim, Henrik & Harboe, Z. B., 2021, In: Clinical Infectious Diseases. 72, 3, p. 463-471 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Clinical outcomes in patients with multi-hit TP53 chronic lymphocytic leukemia treated with ibrutinib

    Brieghel, C., Aarup, K., Torp, M. H., Andersen, M. A., Yde, C. W., Tian, X., Wiestner, A., Ahn, I. E. & Niemann, Carsten, 2021, In: Clinical Cancer Research. 27, 16, p. 4531-4538 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Chatzikonstantinou, T., Kapetanakis, A., Scarfò, L., Karakatsoulis, G., Allsup, D., Cabrero, A. A., Andres, M., Antic, D., Baile, M., Baliakas, P., Bron, D., Capasso, A., Chatzileontiadou, S., Cordoba, R., Correa, J. G., Cuéllar-García, C., De Paoli, L., De Paolis, M. R., Del Poeta, G., Demosthenous, C. & 93 others, Dimou, M., Donaldson, D., Doubek, M., Efstathopoulou, M., Eichhorst, B., El-Ashwah, S., Enrico, A., Espinet, B., Farina, L., Ferrari, A., Foglietta, M., Frederiksen, H., Fürstenau, M., García-Marco, J. A., García-Serra, R., Gentile, M., Gimeno, E., Glenthøj, Andreas Birkedal, Gomes da Silva, M., Gutwein, O., Hakobyan, Y. K., Herishanu, Y., Hernández-Rivas, J. Á., Herold, T., Innocenti, I., Itchaki, G., Jaksic, O., Janssens, A., Kalashnikova, О. B., Kalicińska, E., Karlsson, L. K., Kater, A. P., Kersting, S., Labrador, J., Lad, D., Laurenti, L., Levin, M. D., Lista, E., Lopez-Garcia, A., Malerba, L., Marasca, R., Marchetti, M., Marquet, J., Mattsson, M., Mauro, F. R., Milosevic, I., Mirás, F., Morawska, M., Motta, M., Munir, T., Murru, R., Niemann, Carsten, Rodrigues, R. N., Olivieri, J., Orsucci, L., Papaioannou, M., Pavlovsky, M. A., Piskunova, I., Popov, V. M., Quaglia, F. M., Quaresmini, G., Qvist, K., Reda, G., Rigolin, G. M., Ruchlemer, R., Saghumyan, G., Shrestha, A., Šimkovič, M., Špaček, M., Sportoletti, P., Stanca, O., Stavroyianni, N., Tadmor, T., Te Raa, D., Tonino, S. H., Trentin, L., Van Der Spek, E., van Gelder, M., van Kampen, R., Varettoni, M., Visentin, A., Vitale, C., Wasik-Szczepanek, E., Wróbel, T., San Segundo, L. Y., Yassin, M., Coscia, M., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A., Stamatopoulos, K. & Ghia, P., 2021, In: Leukemia. 35, 12, p. 3444-3454 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial

    Dennis, M., Burnett, A., Hills, R., Thomas, I., Ariti, C., Severinsen, M. T., Hemmaway, C., Greaves, P., Clark, R. E., Copland, M., Russell, N., Kallenbach, M., Culligan, D., Duncan, C., Krishnamurthy, P., Cuthbert, A., Patalappa, C., Spanoudakis, M., Galvani, D., Berkahn, I. & 31 others, Patton, N., Pemberton, L., Virchis, A., Jasani, P., Parker, A., Arnold, C., Cuthbert, R., Finnega, D., Nikolousis, M., Pratt, G., Cahalin, P., Ackroyd, S., Mehta, P., Protheroe, R., Weinkove, R., Ali, S., Welch, E., Smith, M., Spearing, R., Vyas, P., Campbell, G., Hamblin, M., Wood, M., Gupta, S., Westonsmith, S., Pillai, A., Hunter, H., Kjeldsen, L., Niemann, Carsten, Khan, A. & on behalf of the National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group, O. B. O. T. N. C. R. I. (. A. M. L. (. W. G., 2021, In: British Journal of Haematology. 194, 2, p. 298-308 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival

    Egholm, G. J., Andersen, M. A., Andersen, Christen Bertel L, Frederiksen, H., Bjerrum, O. W. & Niemann, Carsten, 2021, In: British Journal of Haematology. 192, 3, p. e81-e84 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    ESMO Guidelines Committee, E. G. C., 2021, In: Annals of Oncology. 32, 1, p. 23-33 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

    Eskelund, C. W., Dimopoulos, K., Kolstad, A., Glimelius, I., Räty, R., Gjerdrum, Lise Mette Rahbek, Sonnevi, K., Josefsson, P., Nilsson-ehle, H., Bentzen, H. H. N., Fagerli, U. M., Kuittinen, O., Haaber, J., Niemann, Carsten, Pedersen, L. B., Larsen, M. T., Geisler, C. H., Hutchings, M., Jerkeman, M. & Grønbæk, Kirsten, 2021, In: HemaSphere. 5, 1, p. 1-9 e510.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Response to Aviv et al

    Helleberg, M., Niemann, Carsten, Moestrup, K. S., Kirk, Ole, Lebech, Anne-Mette & Lundgren, Jens, 2 Aug 2021, In: The Journal of Infectious Diseases. 224, 3, p. 559-561 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  12. Published

    An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

    Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

    Niemann, Carsten, Levin, M., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 2021, In: Blood. 137, 8, p. 1117-1120

    Research output: Contribution to journal › Letter › Research › peer-review

  14. Published

    Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

    Pettengell, R., Uddin, R., Boumendil, A., Johnson, R., Metzner, B., Martín, A., Romejko-Jarosinska, J., Bence-Bruckler, I., Giri, P., Niemann, Carsten, Robinson, S. P., Kimby, E., Schmitz, N., Dreger, P., Goldstone, A. H. & Montoto, S., 2021, In: Bone Marrow Transplantation. 56, 6, p. 1413-1421 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia

    Rotbain, E. C., Rostgaard, K., Andersen, M. A., Da Cunha-Bang, C., Niemann, Carsten, Frederiksen, H. & Hjalgrim, Henrik, 2021, In: Clinical Epidemiology. 13, p. 1155-1165 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death

    Rotbain, E. C., Niemann, Carsten, Rostgaard, K., da Cunha-Bang, C., Hjalgrim, Henrik & Frederiksen, H., 2021, In: Leukemia. 35, p. 2570–2580

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Targeting the tumor microenvironment in chronic lymphocytic leukemia

    Svanberg, R., Janum, S., Patten, P. E. M., Ramsay, A. G. & Niemann, Carsten, 2021, In: Haematologica. 106, 9, p. 2312-2324

    Research output: Contribution to journal › Review › Research › peer-review

  18. Published

    Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

    Wierda, W. G., Rawstron, A., Cymbalista, F., Badoux, X., Rossi, D., Brown, J. R., Egle, A., Abello, V., Cervera Ceballos, E., Herishanu, Y., Mulligan, S. P., Niemann, C. U., Diong, C. P., Soysal, T., Suzuki, R., Tran, H. T. T., Wu, S. J., Owen, C., Stilgenbauer, S., Ghia, P. & 1 others, Hillmen, P., 2021, In: Leukemia. 35, 11, p. 3059-3072 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  19. Published

    Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study

    da Cunha-Bang, C., Rostgaard, K., Andersen, M. A., Rotbain, E. C., Grønbæk, Kirsten, Frederiksen, H., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: British Journal of Haematology. 193, 2, p. 339-345

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 185059285